13 results
424B5
MLYS
Mineralys Therapeutics Inc
11 Apr 24
Prospectus supplement for primary offering
4:35pm
could differ materially from those projected in the forward-looking statements. Moreover, we operate in an evolving environment. New risk factors … -looking statements. Moreover, we operate in an evolving environment. New risk factors and uncertainties may emerge from time to time
S-3
EX-1.2
MLYS
Mineralys Therapeutics Inc
21 Mar 24
Shelf registration
7:30am
, the environment (including, without limitation, ambient air, surface water, groundwater, land surface or subsurface strata) or wildlife, including, without
S-3
MLYS
Mineralys Therapeutics Inc
21 Mar 24
Shelf registration
7:30am
materially from those projected in the forward-looking statements. Moreover, we operate in an evolving environment. New risk factors and uncertainties … in the forward-looking statements. Moreover, we operate in an evolving environment. New risk factors and uncertainties may emerge from time to time
8-K
EX-10.1
4ta 9baa2m2z
8 Feb 24
Mineralys Therapeutics Announces $120 Million Private Placement Financing
4:41pm
10-Q
3ik11wwrezga2fyezwtr
15 May 23
Quarterly report
5:25pm
DRS/A
dcku puqut
29 Dec 22
Draft registration statement (amended)
12:00am
DRS/A
arj5ka9mkafi75rhja
7 Dec 22
Draft registration statement (amended)
12:00am
DRS
rxly5m
4 Nov 22
Draft registration statement
12:00am
DRS
EX-4.2
vxhc6nfewrat vptkub
4 Nov 22
Draft registration statement
12:00am
- Prev
- 1
- Next